QNTM
Quantum BioPharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.24
+9.83%Aug 3, 2026, 17:50 UTC
Quantum BioPharma reached the halfway point in patient enrollment for its pilot MS imaging study with Massachusetts General Hospital, with preliminary PET imaging data showing encouraging signals in acute MS lesions.
Source:Jul 20, 2026, 23:00 UTC
Quantum BioPharma announced its intention to settle debt.
Jun 1, 2026, 23:30 UTC
Quantum BioPharma received FDA notification that its IND for Lucid-MS has been placed on clinical hold.